Unity Biotechnology, Inc.
UBX · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7,302 | -$8,440 | -$6,481 | -$5,279 |
| Dep. & Amort. | $178 | $203 | -$422 | $221 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $617 | $805 | $797 | $974 |
| Change in WC | $101 | $625 | -$2,210 | $1,271 |
| Other Non-Cash | $49 | $902 | $3,123 | -$1,771 |
| Operating Cash Flow | -$6,357 | -$5,905 | -$5,193 | -$4,584 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$974 | -$2,422 | $0 | -$7,830 |
| Inv. Sales/Matur. | $7,750 | $7,000 | $6,500 | $12,500 |
| Other Inv. Act. | $0 | $0 | $7 | $0 |
| Investing Cash Flow | $6,776 | $4,578 | $6,507 | $4,670 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $9 | $0 | $68 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $9 | $0 | $68 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $419 | -$1,318 | $1,314 | $154 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $8,476 | $9,794 | $8,480 | $7,430 |
| End Cash | $8,895 | $8,476 | $9,794 | $7,584 |
| Free Cash Flow | -$6,357 | -$5,905 | -$5,193 | -$4,584 |